Mumbai, May 12, 2022 (GPN): Hetero, India’s leading pharmaceutical company, today unveiled its new corporate logo, brand architecture, visual and verbal identity. With a people-first approach, this distinctive identity will guide and accelerate Hetero’s business growth…
India, Mumbai; 21st March, 2022 (GPN): Hetero, a globally renowned vertically integrated pharmaceutical organization announced today that its biologics arm ‘Hetero Biopharma’ has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture for…
MUMBAI, INDIA, 21st JUNE, 2020 (GPN): Hetero, one of India’s leading generic pharmaceutical companies, announced today that it has received the manufacturing and marketing approval for the investigational antiviral medicine ‘Remdesivir’ from the Drug Controller General of…
INDIA, HYDERABAD, 13th MAY, 2020 (GPN): Hetero, one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs, announced today that it has entered into a licensing agreement with Gilead Sciences, Inc….
